HEC53856 / Sunshine Lake Pharma - LARVOL DELTA

HEC53856-RAD-102: HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia (clinicaltrials.gov) - P1 | N=40 | Completed | Sponsor: Sunshine Lake Pharma Co., Ltd. | Not yet recruiting ➔ Completed | N=60 ➔ 40

Enrollment change • Trial completion • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease

HEC53856-RAD-103: Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. (clinicaltrials.gov) - P1 | N=60 | Completed | Sponsor: Sunshine Lake Pharma Co., Ltd. | Not yet recruiting ➔ Completed

Trial completion • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia (clinicaltrials.gov) - P1; N=60; Not yet recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.

New P1 trial • Anemia • Hematological Disorders • CRP • VEGFA

Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. (clinicaltrials.gov) - P1; N=60; Not yet recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.

New P1 trial • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease • CRP • VEGFA